Skip Navigation


ToxSci Advance Access originally published online on January 12, 2005
Toxicological Sciences 2005 84(2):344-351; doi:10.1093/toxsci/kfi082
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
84/2/344    most recent
kfi082v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Tsuchiya, T.
Right arrow Articles by Umeda, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsuchiya, T.
Right arrow Articles by Umeda, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Toxicological Sciences vol. 84 no. 2 © The Author 2005. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For Permissions, please email: journals.permissions@oupjournals.org

Inorganic Arsenic Compounds and Methylated Metabolites Induce Morphological Transformation in Two-Stage BALB/c 3T3 Cell Assay and Inhibit Metabolic Cooperation in V79 Cell Assay

Toshiyuki Tsuchiya*,1, Toshiko Tanaka-Kagawa{dagger}, Hideto Jinno{dagger}, Hiroshi Tokunaga{dagger}, Kazunori Sakimoto*, Masanori Ando{ddagger} and Makoto Umeda§

* Safety Evaluation Center, Showa Denko K.K., Chiba 267-0056, Japan; {dagger} Division of Environmental Chemistry and Exposure Assessment, National Institute of Health Science, Setagaya-ku, Tokyo 158-8501, Japan; {ddagger} Research Institute of Pharmaceutical Sciences, Faculty of Pharmacy, Musashino University, Nishitokyo-shi, Tokyo 202-8585, Japan; and § Laboratory of Cellular Toxicology, Hatano Research Institute, Food and Drug Safety Center, Hadano, Kanagawa 257-0025, Japan

Received October 22, 2004; accepted January 7, 2005

We have performed two-stage transformation assay using BALB/c 3T3 cells to determine initiating and promoting activities of disodium arsenate, sodium arsenite, monomethylarsonic acid (MMAA) and dimethylarsinic acid (DMAA). Treatment with these arsenic compounds at the initiating stage induced significant numbers of transformed foci when cells were post-treated with 12-O-tetradecanoylphorbol-13-acetate (TPA). Disodium arsenate was active at the concentrations of 15–30 µM, sodium arsenite 5–20 µM, and DMAA 1–2 mM. MMAA required 10 mM to induce cell transformation. The concentrations of these compounds (except DMAA) that induced transformation were highly growth-inhibitory (more than 50%). DMAA induced transformation foci at growth inhibition levels of 66 to 84%. In experiments on promoting activity, cells pretreated with a sub-threshold dose of 20-methylcholanthrene (MCA, 0.2 µg/ml) or sodium arsenite (10 µM) were used. Transformation was enhanced by post-treatment with disodium arsenate (1–10 µM), sodium arsenite (0.5–2 µM), and MMAA (200–1000 µM), but not with DMAA. Studies of gap junctional intercellular communication using the V79 cell metabolic cooperation assay showed that the arsenic compounds (except DMAA) exhibited inhibitory activity. Thus, most arsenicals were shown to have not only initiating activity, but also promoting activity. In addition, inorganic arsenicals, especially trivalent sodium arsenite, were more active than organic ones and exhibited promoting activity at one-order of magnitude lower than initiating activity. These results suggest that from the viewpoint of human hazard, more attention should be paid to the tumor promoting activity of inorganic arsenic compounds.

Key Words: arsenic compounds; BALB/c 3T3 cells; initiating activity; metabolic cooperation; tumor-promoting activity; two-stage cell transformation.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
CarcinogenesisHome page
C.-W. Chien, I-C. Ho, and T.-C. Lee
Induction of neoplastic transformation by ectopic expression of human aldo-keto reductase 1C isoforms in NIH3T3 cells
Carcinogenesis, October 1, 2009; 30(10): 1813 - 1820.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Huang, J. Zhang, K. T. McHenry, M. M. Kim, W. Zeng, V. Lopez-Pajares, C. C. Dibble, J. P. Mizgerd, and Z.-M. Yuan
Induction of Cytoplasmic Accumulation of p53: A Mechanism for Low Levels of Arsenic Exposure to Predispose Cells for Malignant Transformation
Cancer Res., November 15, 2008; 68(22): 9131 - 9136.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.